Related Experiment Videos
Advancing drug discovery through systems biology.
EugeneJ Davidov1, JoanneM Holland, EdwardW Marple
1Beyond Genomics, 40 Bear Hill Road, Waltham, MA 02451, USA. edavidov@beyondgenomics.com
Drug Discovery Today
|February 13, 2003
Summary
Pharmaceutical companies can accelerate drug discovery and innovation by integrating technologies. This approach enhances understanding of biological functions and chemical interactions, leading to improved drug candidate pipelines.
Area of Science:
- Drug Discovery and Development
- Systems Biology
- Bioinformatics
Background:
- Pharmaceutical industry faces pressure to expand drug pipelines and drive innovation.
- Current drug discovery processes encounter significant challenges and limitations.
- Market demands necessitate continuous revenue growth and novel therapeutic solutions.
Purpose of the Study:
- To present an emerging approach for improving drug discovery.
- To address challenges in lead compound and clinical candidate portfolio expansion.
- To highlight the role of technology integration in pharmaceutical innovation.
Main Methods:
- Systematic integration of diverse technologies.
- Leveraging systems biology principles.
- Analyzing chemico-biological interactions and biological functions.
Main Results:
- Enhanced data and information output from integrated technologies.
- Improved understanding of biological systems and drug interactions.
- Facilitation of a more robust drug discovery pipeline.
Conclusions:
- Technology integration, particularly systems biology, offers a solution to current drug discovery hurdles.
- Enhanced understanding of biological and chemical interactions accelerates the identification of viable drug candidates.
- This approach supports pharmaceutical companies in meeting market demands for innovation and growth.